Metabolic Heart Disease

Influence of sex and phenotype on cardiac outcomes in patients with Fabry disease
Mohamed El Sayed, Alexander Hirsch, Matthijs Boekholdt, Laura van Dussen, Mareen Datema, Carla Hollak, Mirjam Langeveld

Heart Dec 2021, 107 (23) 1889-1897; DOI: 10.1136/heartjnl-2020-317922
Prevalence and clinical outcomes of triglyceride deposit cardiomyovasculopathy among haemodialysis patients
Tomohiro Onishi, Yusuke Nakano, Ken-ichi Hirano, Yasuyuki Nagasawa, Toru Niwa, Atomu Tajima, Hideki Ishii, Hiroshi Takahashi, Shinichiro Sakurai, Hirohiko Ando, Hiroaki Takashima, Tetsuya Amano

Heart Jan 2021, 107 (2) 127-134; DOI: 10.1136/heartjnl-2020-317672
Cardiovascular effects of psychotic illnesses and antipsychotic therapy
Sandra Howell, Ekaterina Yarovova, Ahmad Khwanda, Stuart D Rosen

Heart Dec 2019, 105 (24) 1852-1859; DOI: 10.1136/heartjnl-2017-312107
Global longitudinal strain, myocardial storage and hypertrophy in Fabry disease
Ravi Vijapurapu, Sabrina Nordin, Shanat Baig, Boyang Liu, Stefania Rosmini, Joao Augusto, Michel Tchan, Derralynn A Hughes, Tarekegn Geberhiwot, James C Moon, Richard Paul Steeds, Rebecca Kozor

Heart Mar 2019, 105 (6) 470-476; DOI: 10.1136/heartjnl-2018-313699
Cardiomyopathy associated with the Ala143Thr variant of the α-galactosidase A gene
Kati Valtola, Juanita Nino-Quintero, Marja Hedman, Line Lottonen-Raikaslehto, Tomi Laitinen, Maleeha Maria, Ilkka Kantola, Anita Naukkarinen, Markku Laakso, Johanna Kuusisto

Heart Apr 2020, 106 (8) 609-615; DOI: 10.1136/heartjnl-2019-315933
Age-related reduction of myocardial metabolic efficiency: Is it time to routinely measure myocardial metabolism to monitor cardiac health?
Gabriele Fragasso

Heart Jan 2018, 104 (2) 88-89; DOI: 10.1136/heartjnl-2017-311729

Log in using your username and password

Main menu

Log in using your username and password

You are here

Metabolic Heart Disease